- Home
- TRDA vs CLDT Comparison
TRDA vs CLDT Comparison
Compare TRDA & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- CLDT
- Stock Information
- Founded
- TRDA 2016
- CLDT 2009
- Country
- TRDA United States
- CLDT United States
- Employees
- TRDA N/A
- CLDT N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- CLDT Real Estate Investment Trusts
- Sector
- TRDA Health Care
- CLDT Real Estate
- Exchange
- TRDA Nasdaq
- CLDT Nasdaq
- Market Cap
- TRDA 548.2M
- CLDT 450.5M
- IPO Year
- TRDA 2021
- CLDT 2010
- Fundamental
- Price
- TRDA $12.64
- CLDT $8.82
- Analyst Decision
- TRDA Strong Buy
- CLDT Strong Buy
- Analyst Count
- TRDA 3
- CLDT 2
- Target Price
- TRDA $25.67
- CLDT $12.00
- AVG Volume (30 Days)
- TRDA 128.3K
- CLDT 249.4K
- Earning Date
- TRDA 03-12-2025
- CLDT 02-25-2025
- Dividend Yield
- TRDA N/A
- CLDT 3.17%
- EPS Growth
- TRDA N/A
- CLDT N/A
- EPS
- TRDA 1.55
- CLDT N/A
- Revenue
- TRDA $215,232,000.00
- CLDT $313,268,000.00
- Revenue This Year
- TRDA $47.45
- CLDT N/A
- Revenue Next Year
- TRDA N/A
- CLDT $3.83
- P/E Ratio
- TRDA $8.18
- CLDT N/A
- Revenue Growth
- TRDA 146.92
- CLDT 1.77
- 52 Week Low
- TRDA $11.35
- CLDT $7.60
- 52 Week High
- TRDA $21.79
- CLDT $11.10
- Technical
- Relative Strength Index (RSI)
- TRDA 24.83
- CLDT 44.85
- Support Level
- TRDA $12.02
- CLDT $8.65
- Resistance Level
- TRDA $18.76
- CLDT $8.95
- Average True Range (ATR)
- TRDA 0.92
- CLDT 0.22
- MACD
- TRDA -0.51
- CLDT -0.01
- Stochastic Oscillator
- TRDA 9.35
- CLDT 52.11
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.